This isogenic cellular PM model is a unique system and provides a platform to allow for further discoveries and in‐depth insights into harnessing the therapeutic potential of loss of BAP1 and NF2 in mesothelioma, as well as provide a detailed understanding of BAP1 and the Hippo pathway's fundamental biological functions. The gene discussed is NF2; the disease is mesothelioma.